Home/Inipharm/Chuhan Chung, MD

CC

Chuhan Chung, MD

Chief Medical Officer

Therapeutic Areas

Liver Disease Metabolic Dysfunction-Associated Steatohepatitis (MASH)Fibrotic Diseases

Inipharm Pipeline

Drug	Indication	Phase
INI-822	Severe Liver Diseases (MASH)	Phase 1

Leadership Team at Inipharm

Co-Founder, Chief Executive Officer

Heather Hsu, PhD

Co-Founder, Chief Scientific Officer

Sampath Anandan, PhD

View full Inipharm profile